Jason Bottiglieri is an accomplished professional with extensive experience in the medical and telemedicine sectors. Currently serving as General Manager - US at SHL Telemedicine since June 2022, Jason leads initiatives involving advanced ECG technology and cardiology services. Prior roles include Chief Commercial Officer at Elucid, where the focus was on enhancing patient outcomes through AI in diagnostic imaging, and President and CEO of InnovHeart S.r.l., overseeing the development of innovative mitral valve replacement systems. Jason also held prominent leadership positions at Infraredx as President & CEO and Medtronic Peripheral Therapies as Vice President of Global Sales. Earlier career accomplishments include significant roles at Spectranetics and Cordis Cardiology, showcasing a strong background in sales management and training. Jason holds a Bachelor's Degree in Chemistry from Florida Atlantic University and has completed several executive education programs, including those at Harvard Business School and The Wharton School, focusing on finance and marketing strategies.
This person is not in any teams
This person is not in any offices
SHL Telemedicine Ltd
SHL Telemedicine is a world-leading provider of telemedicine services with over 25 years of experience for over a million users.